Clinical Trials Browser

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Endometrial Neoplasms

Breast Neoplasms

Leukemia, Lymphocytic, Chronic, B-Cell

Leukemia, Leukemia, Myeloid, Acute

Lymphoma, Large B-Cell, Diffuse

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Retinoblastoma

Carcinoma, Intraductal, Noninfiltrating

Prostatic Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Oropharyngeal Neoplasms

Prostatic Neoplasms

Mouth Neoplasms

Prostatic Neoplasms

Endometrial Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Mouth Neoplasms

Carcinoma, Non-Small-Cell Lung

Lymphoma, Large B-Cell, Diffuse

Esophageal Neoplasms

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Lymphoma, Lymphoma, Mantle-Cell

Pancreatic Neoplasms

Stomach Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Stomach Neoplasms

Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Vaginal Neoplasms, Vulvar Neoplasms

Multiple Myeloma, Recurrence

Squamous Cell Carcinoma of Head and Neck

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome, Diabetes Mellitus, Hypercholesterolemia, Hypertension, Obesity, Osteoporosis

Brain Neoplasms, Neoplasm Metastasis, Neoplasms

Infections, Multiple Myeloma

Anorexia, Body Weight Changes

Precancerous Conditions, Prostatic Neoplasms

Colorectal Neoplasms

Clinical Trials

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

GIVEN

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

RB SFCE 09

Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast

DIVINE

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

LUMEN-1

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

ATTENUATION

Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma

Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)

PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery

ERLO-XIB

BIMET-1

CheckMate 9TN

ACCORD

Maintenance Treatment With S-1 in Gastric Cancer Patients

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

CARFI

Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

Observation for Patients With Asymptomatic CNS Metastatic Disease

SUTRICA

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Maintenance Treatment With Capecitabine in Colorectal Cancer Patients